ROBIN HART SMITH: Open Payments
NPI 1346612173 · MONROE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$76 in 4 payments from 4 companies in 2025. Trend: 2023 $247 · 2024 $326 · 2025 $76
Food & beverage: $76
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 1 | $26 |
| ABIOMED | 1 | $19 |
| Novo Nordisk Inc | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: VRAYLAR, Ozempic, FARXIGA.
Industry payments across LA — which companies pay providers there.
